Itci stock alert: halper sadeh llc is investigating whether the sale of intra-cellular therapies, inc. is fair to shareholders

New york--(business wire)--halper sadeh llc, an investor rights law firm, is investigating whether the sale of intra-cellular therapies, inc. (nasdaq: itci) to johnson & johnson for $132.00 per share in cash is fair to intra-cellular shareholders. halper sadeh encourages intra-cellular shareholders to click here to learn more about their legal rights and options or contact daniel sadeh or zachary halper at (212) 763-0060 or sadeh@halpersadeh.com or zhalper@halpersadeh.com. the investigation.
ITCI Ratings Summary
ITCI Quant Ranking